Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alloimmunity to RhD in humans.

S J Urbaniak1

  • 1Academic Transfusion Medicine Unit, Department of Medicine and Therapeutics, University of Aberdeen, Foresterhill Road, Aberdeen AB25 2ZW, Scotland, UK. stan.urbaniak@snbts.csa.scot.nhs.uk

Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine
|April 1, 2006
PubMed
Summary

The RhD protein on red blood cells (RBC) is highly immunogenic, leading to anti-D antibodies. Understanding its genetic basis and immune response can help manage transfusion reactions and hemolytic disease of the newborn.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

What's happening--probing of HPA-1a antigen-antibody interaction by surface plasmon resonance technology.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2008
Same author

Noninvasive approaches to the management of RhD hemolytic disease of the fetus and newborn.

Transfusion·2008
Same author

Management of alloimmune thrombocytopenia.

Vox sanguinis·2007
Same author

Repeat ABO-incompatible platelet transfusions leading to haemolytic transfusion reaction.

Transfusion medicine (Oxford, England)·2006
Same author

The analysis and quantification of a clonal B cell response in a hyperimmunized anti-D donor.

Clinical and experimental immunology·2006
Same author

Is there a relationship between anti-HPA-1a concentration and severity of neonatal alloimmune thrombocytopenia?

Immunohematology·2005

Area of Science:

  • Immunology
  • Genetics
  • Hematology

Background:

  • The RhD protein on human red blood cells (RBC) is a major cause of immune reactions.
  • Anti-D antibodies can lead to transfusion complications and hemolytic disease of the newborn.
  • Understanding the RhD protein's immunogenicity is crucial for clinical management.

Purpose of the Study:

  • To elucidate the genetic and molecular basis of RhD protein immunogenicity.
  • To describe the cellular immune response involving T-cells and B-cells against the RhD protein.
  • To explore how differences in RhD protein structure contribute to immune responses.

Main Methods:

  • Analysis of the genetic basis of RhD protein expression.
  • Investigation of the molecular orientation of RhD in the RBC membrane.

Related Experiment Videos

  • Characterization of the adaptive humoral and cellular immune responses to RhD.

    • Main Results:

    • The RhD protein's immunogenicity is linked to its genetic variations and structural features.
    • Conformational B-cell epitopes on extracellular loops stimulate polyclonal antibody responses.
    • Differences of approximately 35 amino acids between RhD and RhCcEe proteins create numerous T-cell epitopes.

    Conclusions:

    • The structural diversity of the RhD protein significantly contributes to its high immunogenicity.
    • Knowledge of RhD epitopes can inform strategies to manipulate immune responses in clinical settings.
    • Further understanding may lead to improved prevention and treatment of RhD-related conditions.